Nature, Published online: 18 December 2024; doi:10.1038/s41586-024-08318-8

Large extrachromosomal DNAs are engineered using a CRISPR- and Cre–loxP-based approach and shown to drive cancer in mouse models, with potential applications in determining the role of oncogene amplifications in human cancers.